Reading time: 2 minutes
iSonea Limited is an emerging medical technology company developing innovative, non-invasive devices and mobile health apps to improve the management of chronic, costly respiratory disorders such as asthma and COPD. The company has developed proprietary respiratory acoustic technologies that enable the capture, storage and objective analysis of respiratory sounds and without relying on patient assistance.
iSonea recently inked a deal with Qualcomm Life, a subsidiary of Qualcomm, to combine iSonea’s proprietary Acoustic Respiratory Monitoring (ARM) devices and forthcoming mobile health asthma management offerings with Qualcomm’s recently launched 2net platform.
The partnership leverages iSonea’s ARM devices, which will collect and transmit patient health data, with Qualcomm Life’s 2net Hub, a plug-and-play connectivity gateway to the cloud-based 2net platform data server. The integration of the two platforms will automatically and securely link patient asthma symptom and trend monitoring data to a cloud-based portal for physicians and caregivers to improve asthma management and outcomes.
According to Michael J. Thomas, Chief Executive Officer of iSonea Limited:
Asthma is a widespread and growing condition that affects 300 million people worldwide and represents a major healthcare cost burden. With our smartphone platform and Qualcomm’s end-to-end wireless systems expertise, we will provide asthma patients with the ability to monitor and report breathing distress symptoms triggered by environmental factors, as well as their response to treatment. Better daily monitoring can lead to improved medication compliance, lower healthcare costs and improved chronic management of asthma. For patients or family members, better monitoring also means more peace of mind.
Source: Business Wire